Abstract
Botulinum toxin type A (BTX-A) has become the most frequently requested nonsurgical procedure performed around the world. The use of BTX-A in cosmetics has expanded greatly since its approval by the Food and Drug Administration for reduction of glabellar rhytids. Experienced clinicians have been using BTX-A in other areas off-label to improve the appearance of rhytids and facial harmony. Adverse effects associated with BTX-A are rare and tend to be mild and temporary, such as bruising, swelling, and pain at injection sites. More serious complications, such as brow ptosis or eyelid ptosis, can occur. These complications can be minimized by a thorough understanding of the anatomy of the face and careful injection technique, which will be outlined in this article.
References
Qaqish C. Botulinum toxin use in the upper face. Atlas Oral Maxillofacial Surg Clin N Am. 2016;24:95–103.
Carruthers J, Fagien S, Mattarasso SL, et al. Consensus recommendations on the use of botulinum toxin type A in facial aesthetics. Plast Reconst Surg. 2004;114:1S–22S.
Coleman K, Carruthers J. Combination therapy with Botox and fillers: the new rejuvenation paradigm. Dermatol Ther. 2006;19:177–88.
Carruthers J, Carruthers A. Botulinum toxin in facial rejuvenation: an update. Dermatol Clin. 2009;27(4):417–25.
American Society of Plastic Surgeons. New statistics reflect the changing face of plastic surgery. https://www.plasticsurgery.org/news/press-releases/new-statistics-reflect-the-changing-face-of-plastic-surgery
Tremaine AM, McCullough JL. Botulinum toxin type A for the management of glabellar rhytids. Clin Cosmet Investig Dermatol. 2013;3:15–23.
Ramirez-Castaneda J, Jankovic J. Long-term efficacy and safety of botulinum toxin injections in dystonia. Toxins. 2013;5(2):249–66.
Carruthers JDA, Carruthers JA. Treatment of glabellar frown lines with C. Botulinum A exotoxin. In: Carruthers J, Carruthers A. Botulinum toxin in facial rejuvenation: an update.
Botox Cosmetic OnabotulinumtoxinA: full prescribing information. Allergan Inc. 2010. http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/103000s5236lbl.pdf
Xeomin IncobotulinumtoxinA: full prescribing information. Merz Pharmaceuticals, LLC. 2010. http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/125360lbl.pdf
Dysport AbobotulinumtoxinA: full prescribing information. Ipsen Pharmaceuticals and Galderma Laboratories. 2016. https://www.dysport.com/pdfs/Dysport_Full_Prescribing_Information.pdf.
Chen JJ, Dashtipour K. Abo-, inco-, ona-, and rima-botulinum toxins in clinical therapy: a primer. Pharmacotherapy. 2013;33(3):304–18.
Klein AW. Contraindications and complications with the use of botulinum toxin. Clin Dermatol. 2004;22(1):66–75.
Matarasso SL, Matarasso A. Treatment guidelines for botulinum toxin type A for the periocular region and a report on partial upper lip ptosis following injections to the lateral canthal rhytids. Plast Reconstr Surg. 2001;108(1):215–7.
Rzany B, Zielke H. Safety of botulinum toxin in aesthetic medicine. In: Botulinum toxin in aesthetic medicine. Berlin: Springer; 2007. p. 119–25.
Klein AW. Complications, adverse reactions, and insights with the use of botulinum toxin. Dermatol Surg. 2003;29(5):548–56.
Brodsky MA, Swope DM, Grimes D. Diffusion of botulinum toxins. In: Louis ED, editor. Tremor Other Hyperkinet Mov. 2012;2:tre-02-85-417-1.
Matarasso A, Shafer D. Botulinum toxin injections for facial rejuvenation. In: Nahai F, editor. The art of aesthetic surgery: principles and techniques. 2nd ed. St Louis, MO: Quality Medicine Publishing; 2011. p. 243–6. (4 in Qaquish).
Sorensen EP, Urman C. Cosmetic complications: rare and serious events following botulinum toxin and soft tissue filler administration. J Drugs Dermatol. 2015;14(5):486–91.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Florin, W., Haiavy, J. (2018). Complications in the Cosmetic Use of Botulinum Toxin Type A: Prevention and Management. In: Ferneini, E., Castiglione, C., Banki, M. (eds) Complications in Maxillofacial Cosmetic Surgery. Springer, Cham. https://doi.org/10.1007/978-3-319-58756-1_12
Download citation
DOI: https://doi.org/10.1007/978-3-319-58756-1_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-58755-4
Online ISBN: 978-3-319-58756-1
eBook Packages: MedicineMedicine (R0)